Breast cancer tissue bank aims to predict who will relapse

NCT ID NCT02050750

First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 19 times

Summary

This study creates a bank of breast cancer tissue samples from 600 patients who previously took part in the TAILORx trial. Researchers will analyze the tissue to find biological markers that can predict if the cancer will come back or resist hormone therapy or chemotherapy. No new treatments are given; the goal is to improve future treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Adelaide and Meath National Children's Hospital Tallaght

    Dublin, 24, Ireland

  • Beaumont Hospital

    Dublin, 9, Ireland

  • Bons Secours Hospital

    Cork, Ireland

  • Cork University Hospital

    Cork, Ireland

  • Galway University Hospital

    Galway, Ireland

  • Letterkenny General Hospital

    Donegal, Ireland

  • Mater Misericordiae University Hospital

    Dublin, Ireland

  • Midwestern Regional Hospital

    Limerick, Ireland

  • Sligo General Hosptial

    Sligo, Ireland

  • St James Hospital

    Dublin, 8, Ireland

  • St Vincent Universtiy Hospital

    Dublin, 4, Ireland

  • Waterford Regional Hospital

    Waterford, Ireland

Conditions

Explore the condition pages connected to this study.